Journal of Materials Science

, Volume 54, Issue 5, pp 4246–4258 | Cite as

Silk fibroin coaxial bead-on-string fiber materials and their drug release behaviors in different pH

  • Huanjie Xi
  • Huijing ZhaoEmail author
Materials for life sciences


Inspired by the different pH between normal tissue and tumor tissue, pH-responsive drug release materials need to be designed to achieve drug-controlled release. Electrospinning is a simple and efficient method to fabricate drug loading and releasing materials. However, burst release of electrospun smooth fibers was often observed in drug delivery process, which is very harmful to the human body. To develop materials with drug sustained release behaviors in tumor tissue environment, different morphologies of electrospun materials should be designed and fabricated. In this study, silk fibroin smooth fiber materials, bead-on-string fiber materials and coaxial bead-on-string fiber materials were fabricated and their drug release behaviors were compared in different pH. The drug release experiments showed that the electrospun materials showed pH-sensitive releasing behaviors. They released faster and more amount of drugs in acid buffer. Besides, the electrospun coaxial bead-on-string fiber material has a slower release rate compared with the smooth fiber and bead-on-string fiber materials. The coaxial bead-on-string fiber material is an efficient and of potential for being used as sustained drug delivery system to treat cancers.



We sincerely thank people from EMPA, St.Gallen, Switzerland, for their suggestions and supports. They are Dr. Riccardo Innocenti Malini, Dr. Amin Sadeghpour, Dr. Giuseppino Fortunato, Dr. Fabrizio Spano and Professor René M. Rossi.


This study was funded by Natural Science Foundation of Jiangsu Province (Grant Nos. BK20161254 and BK2012634) and National Natural Science Foundation of China (Grant No. 51103092).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.


  1. 1.
    Langer R (1998) Drug delivery and targeting. Nature 392:5–10Google Scholar
  2. 2.
    Brouwers JR (1996) Advanced and controlled drug delivery systems in clinical disease management. Pharm World Sci 18:153–162CrossRefGoogle Scholar
  3. 3.
    Uhrich KE, Cannizzaro SM, Langer RS, Shakesheff KM (1999) Polymeric systems for controlled drug release. Chem Rev 99:3181–3198CrossRefGoogle Scholar
  4. 4.
    Panyam J, Labhasetwar V (2003) Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 55:329–347CrossRefGoogle Scholar
  5. 5.
    Tian L, Prabhakaran MP, Ding X, Kai D, Ramakrishna S (2012) Emulsion electrospun vascular endothelial growth factor encapsulated poly(l-lactic acid-co-ε-caprolactone) nanofibers for sustained release in cardiac tissue engineering. J Mater Sci 47:3272–3281. CrossRefGoogle Scholar
  6. 6.
    Somvipart S, Kanokpanont S, Rangkupan R, Ratanavaraporn J, Damrongsakkul S (2013) Development of electrospun beaded fibers from Thai silk fibroin and gelatin for controlled release application. Int J Biol Macromol 55:176–184CrossRefGoogle Scholar
  7. 7.
    Thakur RA, Florek CA, Kohn J, Michniak BB (2008) Electrospun nanofibrous polymeric scaffold with targeted drug release profiles for potential application as wound dressing. Int J Pharm 364:87–93CrossRefGoogle Scholar
  8. 8.
    Qi H, Hu P, Xu J (2006) Encapsulation of drug reservoirs in fibers by emulsion electrospinning: morphology characterization and preliminary release assessment. Biomacromol 7:2327–2330CrossRefGoogle Scholar
  9. 9.
    Frokjaer S, Otzen D (2005) Protein drug stability: a formulation challenge. Nat Rev Drug Discov 4:298–306CrossRefGoogle Scholar
  10. 10.
    Zhang Y, Ouyang H, Lim CT, Ramakrishna S, Huang Z (2005) Electrospinning of gelatin fibers and gelatin/PCL composite fibrous scaffolds. J Biomed Mater Res B 72B:156–165CrossRefGoogle Scholar
  11. 11.
    Zhao H, Chi H (2018) Chapter 5: bead-on-string nanofibers: useless or something of value? In: Lin T (ed) Novel aspects of nanofibers. IntechOpen Limited, pp 87–102. ISBN 978-1-78923-075-8Google Scholar
  12. 12.
    Zhang Y, Wang X, Feng Y (2006) Coaxial electrospinning of (fluorescein isothiocyanate-conjugated bovine serum albumin)-encapsulated poly(ε-caprolactone) nanofibers for sustained release. Biomacromol 7:1049–1057CrossRefGoogle Scholar
  13. 13.
    Han F, Liu S, Liu X, Pei Y, Bai S, Zhao H et al (2014) Woven silk fabric-reinforced silk nanofibrous scaffolds for regenerating load-bearing soft tissues. Acta Biomater 10:921–930CrossRefGoogle Scholar
  14. 14.
    Rockwood DN, Preda RC, Yücel T, Wang X, Lovett ML, Kaplan DL (2011) Materials fabrication from Bombyx mori silk fibroin. Nat Protoc 6:1612–1631CrossRefGoogle Scholar
  15. 15.
    Cakmak S, Cakmak AS, Kaplan DL, Gumusderelioglu M (2013) A silk fibroin and peptide amphiphile-based co-culture model for osteochondral tissue engineering. Macromol Biosci 16:1212–1226CrossRefGoogle Scholar
  16. 16.
    He J, Cheng Y, Cui S (2013) Preparation and characterization of electrospun Antheraea pernyi silk fibroin nanofibers from aqueous solution. J Appl Polym Sci 128:1081–1088CrossRefGoogle Scholar
  17. 17.
    Altman GH, Horan RL, Lu HH, Moreau J, Martin I, Richmond JC, Kaplan DL (2002) Silk matrix for tissue engineered anterior cruciate ligaments. Biomaterials 23:4131–4141CrossRefGoogle Scholar
  18. 18.
    Liu H, Fan H, Wang Y, Toh SL, Goh JCH (2008) The interaction between a combined knitted silk scaffold and microporous silk sponge with human mesenchymal stem cells for ligament tissue engineering. Biomaterials 29:662–674CrossRefGoogle Scholar
  19. 19.
    Unger R (2004) Growth of human cells on a non-woven silk fibroin net: a potential for use in tissue engineering. Biomaterials 25:1069–1075CrossRefGoogle Scholar
  20. 20.
    Wang Y, Kim H, Vunjak-Novakovic G, Kaplan DL (2006) Stem cell-based tissue engineering with silk biomaterials. Biomaterials 27:6064–6082CrossRefGoogle Scholar
  21. 21.
    Tsioris K, Raja WK, Pritchard EM, Panilaitis B, Kaplan DL, Omenetto FG (2012) Fabrication of silk microneedles for controlled-release drug delivery. Adv Funct Mater 22:330–335CrossRefGoogle Scholar
  22. 22.
    Vepari C, Kaplan DL (2007) Silk as a biomaterial. Prog Polym Sci 32:991–1007CrossRefGoogle Scholar
  23. 23.
    Wenk E, Merkle HP, Meinel L (2011) Silk fibroin as a vehicle for drug delivery applications. J Control Release 150:128–141CrossRefGoogle Scholar
  24. 24.
    Tarallo O (2002) Encyclopedia of polymer science and technology. Wiley, New YorkGoogle Scholar
  25. 25.
    Garric X, Guillaume O, Dabboue H, Vert M, Moles J (2012) Potential of a PLA-PEO-PLA-based scaffold for skin tissue engineering: in vitro evaluation. J Biomat Sci Polym E 23:1687–1700Google Scholar
  26. 26.
    Ifkovits JL, Burdick JA (2007) Review: photopolymerizable and degradable biomaterials for tissue engineering applications. Tissue Eng 13:2369–2385CrossRefGoogle Scholar
  27. 27.
    Jin H, Fridrikh SV, Rutledge GC et al (2002) Electrospinning Bombyx mori silk with poly(ethylene oxide). Biomacromol 3(6):1233–1239CrossRefGoogle Scholar
  28. 28.
    Jin H (2004) Human bone marrow stromal cell responses on electrospun silk fibroin mats. Biomaterials 25(6):1039–1047CrossRefGoogle Scholar
  29. 29.
    Wang M, Yu JH, Kaplan DL et al (2006) Production of submicron diameter silk fibers under benign processing conditions by two-fluid electrospinning. Macromolecules 39(3):1102–1107CrossRefGoogle Scholar
  30. 30.
    Li K, Liu H, Gao W, Chen M, Zeng Y, Liu J et al (2015) Mulberry-like dual-drug complicated nanocarriers assembled with apogossypolone amphiphilic starch micelles and doxorubicin hyaluronic acid nanoparticles for tumor combination and targeted therapy. Biomaterials 39:131–144CrossRefGoogle Scholar
  31. 31.
    Sun Y, Liu Y, Zhao G, Zhou X, Gao J, Zhang Q (2008) Preparation of pH-responsive silver nanoparticles by RAFT polymerization. J Mater Sci 43:4625–4630. CrossRefGoogle Scholar
  32. 32.
    Chen H, Kuang Y, Liu R, Chen Z, Jiang B, Sun Z, Chen X, Li C (2018) Dual-pH-sensitive mesoporous silica nanoparticle based drug delivery system for tumor-triggered intracellular drug release. J Mater Sci 53:10653–10665. CrossRefGoogle Scholar
  33. 33.
    Duan X, Wu Y, Ma S, Du J, Zhang S, Chen H, Kong H (2017) Amphiphilic polymer–drug conjugates based on acid-sensitive 100% hyperbranched polyacetals for cancer therapy. J Mater Sci 52:9430–9440. CrossRefGoogle Scholar
  34. 34.
    Pan J, Lei S, Chang L, Wan D (2018) Smart pH-responsive nanoparticles in a model tumor microenvironment for enhanced cellular uptake. J Mater Sci 20:1573–4803. Google Scholar
  35. 35.
    Qi R, Tian X, Guo R, Luo Y, Shen M, Yu J, Shi X (2016) Controlled release of doxorubicin from electrospun MWCNTs/PLGA hybrid nanofibers. Chin J Polym Sci 34:1047–1059CrossRefGoogle Scholar
  36. 36.
    Chen Y, Qi Y, Liu B (2013) Polyacrylic acid functionalized nanographene as a nanocarrier for loading and controlled release of doxorubicin hydrochloride. J Nanomater 2013:1–8Google Scholar
  37. 37.
    Ardeshirzadeh B, Anaraki NA, Irani M, Rad LR, Shamshiri S (2015) Controlled release of doxorubicin from electrospun PEO/chitosan/graphene oxide nanocomposite nanofibrous scaffolds. Mater Sci Eng C 48:384–390CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.National Engineering Laboratory for Modern Silk, College of Textile and Clothing EngineeringSoochow UniversitySuzhouChina

Personalised recommendations